Preclinical

TB-500

Thymosin Beta-4 fragment / TB-500

Healing & Recovery

TB-500 is usually discussed in the context of tissue repair, mobility, inflammation signaling, and recovery-related mechanisms connected to thymosin beta-4 biology. Public claims often run ahead of the clinical evidence, so it should be treated as an evidence-limited research topic rather than an established recovery therapy.

Research status: Preclinical research only — no human clinical trials published

Deep Dives on TB-500

Start here for the plain-English articles connected to this peptide.

Safety Guides14 min read

TB-500 Side Effects and Unknowns: What Safety Evidence Actually Shows

TB-500 is often discussed as a recovery peptide, but its human safety profile is still uncertain. Here is what is known, what is not known, and how to read side-effect claims carefully.

Read article

Compound Profiles7 min read

What Is TB-500? An Evidence-Aware Overview

An evidence-aware overview of TB-500, its relationship to thymosin beta-4, what it is commonly discussed for, and where the evidence remains limited.

Read article

Quick Facts

Origin: Synthetic peptide associated with thymosin beta-4 research and related fragment discussions
Amino acids: 43
Category: Healing & Recovery

Mechanisms

Associated with thymosin beta-4 biology and actin-related cellular processes
Discussed for tissue repair, cell migration, and recovery-related mechanistic pathways
Human recovery claims remain limited and should not be treated as established clinical outcomes

Research Areas

Tissue repairRecovery mechanismsInflammation signalingMobility